What Will the Best Business Models Be for Virtual Care in Diabetes?

Diabetes is one of the therapeutic areas where virtual care solutions have the highest penetration and have shown strong clinical and economic evidence so far. In such a competitive market, how can companies stand out from the crowd? How can companies build future-proof business models? 

Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space. More specifically we will discuss:

• What are the future market expectations for virtual care solutions in diabetes? How can companies build future-proof business models?

• Have pharma and medtech proven to be good partners for virtual care companies in diabetes? Will these partnerships continue to be an important model for virtual care companies?

• What will be the best alternative business models? 

• Testing multiple business models: how can virtual care companies in diabetes test different models, to find which suits them, without losing progress and scalability?

• Revenue models: how to choose the right pricing strategy to guarantee ROI? How flexible do these need to be to adapt to market conditions?

• How can companies be smart about price anchors to maximize both adoption and commercial viability?